Parmax Pharma Ltd () Total Returns | Historical Performance, Beta, Dividend Yield & SENSEX Comparison

Parmax Pharma VS Pharmaceuticals & Biotechnology

1.54%

0.36%

-1.38%

-0.16%

5.39%

2.53%

YTD

-20.9%

9.51%

-29.58%

4.66%

-5.28%

36.19%

11.82%

89.83%

10Y

233.77%

Stock Absolute Returns
Absolute Returns

Price + Dividend

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-1.46%

6 Months

-16.23%

1 Year

-29.58%

2 Years

12.87%

3 Years

-5.28%

4 Years

-14.43%

5 Years

11.82%

Parmax Pharma for the last several years.

Return Quartiles

What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.

Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers

Underperformer

Parmax Pharma Ltd has been in the Third and Fourth Quartile in the YTD and longer periods

Quartile

QTD

9.53%

Quartile

Jun-Sep

-20.13%

Quartile

Mar-Jun

-6.72%

Quartile

YTD

-30.64%

Quartile

2024

35.86%

Quartile

2023

-15.84%

Click on any of the quartiles for detailed breakdown

Return Quartiles - by Industry

Inconsistent Performance

Parmax Pharma Ltd has not been a consistent performer in the YTD and longer periods

Quartile

QTD

9.53%

Quartile

Jun-Sep

-20.13%

Quartile

Mar-Jun

-6.72%

Quartile

YTD

-30.64%

Quartile

2024

35.86%

Quartile

2023

-15.84%

Click on any of the quartiles for detailed breakdown

Return Quartiles - by Market Cap

Not enough Stock Price history for Quartile Analysis

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available